The Latest

Pressure Mounts on Truvada PrEP Pricing With Lawsuit and Congressional Hearings

"This isn't about you," Rep. Alexandria Ocasio-Cortez (D-NY) told Gilead CEO Daniel O'Day. "We have legislated a system that allows [this] to happen."

By Tim Murphy

Will Recent Gilead Patent Concessions on Truvada Lower PrEP Prices?

Activists say this relatively small giveaway won't advance PrEP access or help end HIV in the U.S. the way a true price reduction would.

By Tim Murphy

If Nobody Slashes the Price of Truvada for PrEP, What Happens Next?

Activists and doctors say they're ready to go further if Gilead won't agree to -- or the U.S. government won't force -- a price reduction to make PrEP accessible to more Americans who need it.

By Tim Murphy

How Activists Uncovered CDC's Ownership of Truvada PrEP Patents

The #PrEP4All campaign made the call for affordable pre-exposure prophylaxis a national news story.

By Charles Sanchez

Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

But a survey reveals that about a third of black and Latino gay men would be willing to pay more than $50 per month for a prescription.

By Sony Salzman

Doctors Aren't Offering Young People PrEP. That Has to Change.

For LGBT Health Awareness Week, educator Tyunique Nelson argues that PrEP education and access for youth have to be a top priority.

By Tyunique Nelson

PrEP Pricing Is the Elephant in the Room at the CDC National HIV Prevention Conference

In a debate during a plenary session, Michael Saag, M.D., argued for more activism to make PrEP accessible to people who need it.

By Sony Salzman

Stop Blaming PrEP for the Rise in STIs -- the Picture Is More Complex Than That

"PrEP must not be cast as the lone villain in the syphilis crisis, nor MSM engaging in chemsex cast as debauched vectors of transmission."

By Oli Stevens and T Charles Witzel for The Conversation

States Innovate to Expand PrEP Availability and Uptake

As part of comprehensive efforts to reduce the number of new HIV infections, some states are innovating to make HIV pre-exposure prophylaxis (PrEP) more accessible to individuals at high risk of HIV.

By HIV.gov

Chemsex and PrEP Reliance Are Fuelling a Rise in Syphilis Among Men Who Have Sex With Men

Syphilis is back and spreading quickly. What makes the resurgence of syphilis somewhat different this time is that the vast majority of these new cases are being found among men who have sex with men.

By Simon Bishop for The Conversation